$17.05
+0.43 (+2.59%)
Open$16.55
Previous Close$16.62
Day High$17.05
Day Low$16.55
52W High$17.57
52W Low$3.67
Volume—
Avg Volume11.0K
Market Cap88.21M
P/E Ratio1.94
EPS$7.89
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
-18.9% upside
Current
$17.05
$17.05
Target
$13.83
$13.83
$9.36
$13.83 avg
$17.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 797.3K | 116.64M | 118.58M |
| Net Income | -8,343,603 | -21,434,773 | -22,545,743 |
| Profit Margin | -1,046.4% | -18.4% | -19.0% |
| EBITDA | -31,455,407 | -23,823,087 | -23,688,809 |
| Free Cash Flow | — | -12,084,786 | -12,382,292 |
| Rev Growth | — | -8.2% | -9.4% |
| Debt/Equity | — | 0.42 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |